ATE192458T1 - Merosin, dafür kodierende nukleinsäuren, fragmente und deren verwendung - Google Patents

Merosin, dafür kodierende nukleinsäuren, fragmente und deren verwendung

Info

Publication number
ATE192458T1
ATE192458T1 AT91904841T AT91904841T ATE192458T1 AT E192458 T1 ATE192458 T1 AT E192458T1 AT 91904841 T AT91904841 T AT 91904841T AT 91904841 T AT91904841 T AT 91904841T AT E192458 T1 ATE192458 T1 AT E192458T1
Authority
AT
Austria
Prior art keywords
merosin
fragments
nucleic acids
acids coding
laminin
Prior art date
Application number
AT91904841T
Other languages
English (en)
Inventor
Eva Engvall
Ilmo Leivo
Joshua R Sanes
Original Assignee
Jolla Cancer Res Found
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found, Univ Washington filed Critical Jolla Cancer Res Found
Application granted granted Critical
Publication of ATE192458T1 publication Critical patent/ATE192458T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
AT91904841T 1990-01-30 1991-01-30 Merosin, dafür kodierende nukleinsäuren, fragmente und deren verwendung ATE192458T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47231990A 1990-01-30 1990-01-30
US58768990A 1990-09-24 1990-09-24
PCT/US1991/000631 WO1991011462A2 (en) 1990-01-30 1991-01-30 Merosin, nucleic acids encoding, fragments and uses thereof

Publications (1)

Publication Number Publication Date
ATE192458T1 true ATE192458T1 (de) 2000-05-15

Family

ID=27043723

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91904841T ATE192458T1 (de) 1990-01-30 1991-01-30 Merosin, dafür kodierende nukleinsäuren, fragmente und deren verwendung

Country Status (8)

Country Link
US (1) US5444158A (de)
EP (1) EP0514481B1 (de)
JP (1) JPH05506435A (de)
AT (1) ATE192458T1 (de)
AU (1) AU7334291A (de)
CA (1) CA2074361A1 (de)
DE (1) DE69132159T2 (de)
WO (1) WO1991011462A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872231A (en) * 1990-01-30 1999-02-16 La Jolla Cancer Research Foundation Nucleic acids encoding merosin
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5770562A (en) * 1991-03-26 1998-06-23 Oregon Health Sciences University Products and methods for improving keratinocyte adhesion to the dermis
US5863743A (en) * 1994-08-12 1999-01-26 University Of Iowa Research Foundation Merosin deficiency-type congenital muscular dystrophy
WO2000066732A2 (en) 1999-04-30 2000-11-09 Biostratum, Inc. Laminin 8 and methods for its use
US6703363B1 (en) 1999-04-30 2004-03-09 Biostratum, Inc. Recombinant laminin 5
EP1173568A2 (de) 1999-04-30 2002-01-23 University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School Laminin 2 und methoden zur verwendung
HRP20140657T1 (hr) * 2007-10-09 2014-11-07 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno Laminin-1 za primjenu radi pojaäśanja regeneracije mišiä†a nakon ozljede ili za bolje zacjeljivanje rana ako se daje sistemski
KR101219512B1 (ko) * 2011-03-15 2013-01-11 서울대학교산학협력단 세포 부착, 퍼짐, 이동 및 신경돌기 성장을 촉진하는 인간 라미닌 α2 사슬의 LG3 도메인 및 활성 펩티드
US9566310B2 (en) 2012-09-10 2017-02-14 Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno Methods of treating muscular dystrophy
JP2016516051A (ja) 2013-03-15 2016-06-02 ボード オブ リージェンツ オブ ザ ネヴァダ システム オブ ハイヤー エデュケーション オン ビハーフ オブ ザ ユニヴァーシティー オブ ネヴァダ リノ 筋ジストロフィーを治療する方法
WO2019246125A1 (en) * 2018-06-18 2019-12-26 Research Institute At Nationwide Children's Hospital Recombinant adeno-associated virus products and methods for treating dystroglycanopathies and laminin-deficient muscular dystrophies
AR131080A1 (es) * 2022-12-21 2025-02-12 Cristalia Produtos Quim Farmaceuticos Ltda Procesos de extracción, purificación y polimerización de laminina, uso, polilaminina y kit

Also Published As

Publication number Publication date
WO1991011462A3 (en) 1991-10-03
WO1991011462A2 (en) 1991-08-08
DE69132159D1 (de) 2000-06-08
EP0514481B1 (de) 2000-05-03
JPH05506435A (ja) 1993-09-22
EP0514481A1 (de) 1992-11-25
US5444158A (en) 1995-08-22
CA2074361A1 (en) 1991-07-31
AU7334291A (en) 1991-08-21
DE69132159T2 (de) 2001-01-11

Similar Documents

Publication Publication Date Title
ATE192458T1 (de) Merosin, dafür kodierende nukleinsäuren, fragmente und deren verwendung
DE3586853D1 (de) Immunologisch aktive peptide, geeignet zur einfuehrung von immunisierung gegen malaria und deren kodierung von genen.
DE69001275D1 (de) Satz zur herstellung und abscheidung von endothelzellen.
DE69300497D1 (de) Silberkatalysator zur Herstellung von Äthylenoxid.
ATE263251T1 (de) Rekombinanter bakulovirus und sein verwendung zur herstellung monoklonaler antikörper
BG102162A (en) Substituted (sulpphinic acid, sulphonic acid, sulphonylamino or sulphinylamino)n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylam ide compounds
HUP9802994A2 (hu) Polimer szerkezeti anyag, eljárás annak előállítására, és alkalmazása
DE3484391D1 (de) Herstellung von peptiden und deren verwendung.
DE69316782D1 (de) Verwendung von Polymerzusammensetzungen zur Herstellung von warmverschweissbaren Dachbahnen
DE3889350D1 (de) Kautschukzusammensetzung und ihre Verwendung bei der Herstellung von Packungen und Schläuchen.
DE59813875D1 (de) Ko-stimulierendes polypeptid von t-zellen, monoklonale antikörper sowie die herstellung und deren verwendung
DE69627659D1 (de) Neue thrombin-inhibitoren, deren herstellung und verwendung
ATA189691A (de) Hpth-peptide, ihre herstellung und verwendung
DE59002517D1 (de) Presslinge auf Basis von pyrogen hergestelltem Siliciumdioxid, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE59407394D1 (de) Verwendung von polyacetalen zur herstellung von kompostierbaren formkörpern
NO995182L (no) Pattedyrcytokinlignende faktor 7
DE69219590D1 (de) BPC-Peptide, deren Herstellung und Verwendung
ATE262537T1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
DE69510594D1 (de) Herstellung von magnetostriktiven Material
DE68921447D1 (de) Katalytische Herstellung von linearen Polyethylenpolyaminen.
DE69626462T2 (de) Herstellung von Gas
DE59405004D1 (de) Herstellung von 2-H-Heptafluorpropan
DE69001940D1 (de) Kontinuierliche herstellung von polyesterfaeden.
ES2052513T3 (es) Nuevos polipeptidos, su fabricacion y empleo.
ATE110320T1 (de) Herstellung von behältern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties